Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001615774-16-007912
Filing Date
2016-10-31
Accepted
2016-10-31 16:37:07
Documents
1
Period of Report
2016-10-31

Document Format Files

Seq Description Document Type Size
1 4 s104485_form4.html 4  
1 4 s104485_form4.xml 4 10987
  Complete submission text file 0001615774-16-007912.txt   12475
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Issuer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TONIX PHARMACEUTICALS HOLDING CORP 509 MADISON AVE., SUITE 306 NEW YORK NY 10022
Business Address
LEDERMAN SETH (Reporting) CIK: 0001563420 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36019 | Film No.: 161962071